BNP Paribas Financial Markets Raises Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

BNP Paribas Financial Markets raised its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 28.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 47,295 shares of the medical instruments supplier's stock after acquiring an additional 10,388 shares during the period. BNP Paribas Financial Markets owned approximately 0.22% of Mettler-Toledo International worth $57,874,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. JPMorgan Chase & Co. raised its stake in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after acquiring an additional 28,478 shares during the period. Allworth Financial LP boosted its holdings in shares of Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after purchasing an additional 169 shares during the period. Nordea Investment Management AB increased its position in Mettler-Toledo International by 29.8% during the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock valued at $129,919,000 after acquiring an additional 24,285 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its position in Mettler-Toledo International by 18.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after acquiring an additional 5,234 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its position in Mettler-Toledo International by 773.3% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock valued at $6,530,000 after acquiring an additional 4,725 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Trading Up 6.9%

MTD traded up $74.32 on Monday, hitting $1,155.30. The company had a trading volume of 80,892 shares, compared to its average volume of 145,432. The firm has a market cap of $24.01 billion, a P/E ratio of 28.44, a PEG ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a 1 year low of $946.69 and a 1 year high of $1,546.93. The company's fifty day moving average price is $1,118.64 and its 200 day moving average price is $1,222.47.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $8.89 earnings per share. On average, analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Evercore ISI lifted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research report on Monday, February 10th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their target price for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a report on Monday, April 7th. Finally, StockNews.com lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $1,296.13.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. This represents a 51.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.